- Fee assured
- Verified this account
- Skin cancer
Girish provides a full clinical programme in both medical and surgical dermatology. Since 2005, he has focused on the management of skin cancer and he was appointed as the Clinical Lead for the West of Scotland skin cancer network from 2009 to 2014. He was also a member of the National Cancer Research Institute skin cancer group from 2014 to 2017.
Girish has specialist interests in the Management of skin cancer, Mole screening, Topical therapy of pre-cancerous skin conditions and Tele-dermatology.
He has published extensively in peer-reviewed journals and has written a chapter on skin cancer in the international Textbook of Dermatology. In 2015, he was appointed Honorary Clinical Associate Professor by the University of Glasgow.
Areas of interest
Skin cancer management; Mole and lesion assessment
- Caroline Heron
Current NHS consultant posts held
Consultant Dermatologist, NHS Lothian.
Honorary Clinical Associate Professor, University of Glasgow.
Honorary Consultant Dermatologist, Greater Glasgow and Clyde.
Topical therapy of pre-malignant conditions
(Additional) Languages spoken
- Hindi - Fluent
Gupta G, Madan V, Lear J. Squamous cell carcinoma and its precursors. In: Rook’s Textbook of Dermatology, Ninth edition (Griffiths CEM, Barker J, Chalmers RJG, Bleiker TO, Creamer D, eds), Wiley Blackwell, Oxford 2016; 142: 1-142.42
Blair R, Gupta G. Impact of demographic and treatment-related factors. In: Adherence in Dermatology (Davis SA, eds), Springer 2016: 17-27
Rosacea – Primary Care Treatment Pathway. PCDS. 2016
PAPERS AND CASE REPORTS
Schmitz L, Gambichler T, Kost C, Gupta G, Stücker M, Stockfleth E, Dirschka T. Cutaneous squamous cell carcinomas are associated with basal proliferating actinic keratoses. Br J Dermatol (in press)
Schmitz L, Gupta G, von Dobbeler C, Gambichler T, Szeimies RM, Morton C, Dirschka T. Photodynamic therapy leads to significant improvement of actinic keratosis area and severity index (AKASI). Photodiagnosis Photodyn Ther 2018; 21: 66-70
Schmitz L, Gupta G, Segert MH, Kost R, Sternberg J, Gambichler T, Dirschka T. Diclofenac sodium 3% in hyaluronic acid 2.5% gel significantly diminishes actinic keratosis area and severity index (AKASI). Skin Pharmacol Physiol 2018; 31: 206-211
Pellacani G, Gupta G, Micali G, Malvehy J, Stratigos AJ, Casari A, Cheseter J, Kaleci S, Dirschka T. Actinic keratosis area severity index (AKASI): Reproducibility study and comparison with total lesion count. Br J Dermatol 2018; 179: 763-764
Morton CA, Dominicus R, Radny P, Dirschka T, Hauschild A, Reinhold U, Aschoff R, Ulrich M, Keohane S, Ekanayake-Bohlig S, Ibbotson S, Ostendorf R, Berking C, Gröne D, Schulze HJ, Ockenfels HM, Jasnoch V, Kurzen H, Sebastian M, Stege H, Staubach-Renz P, Gupta G, Hübinger F, Ziabreva I, Schmitz B, Gertzmann A, Lübbert H, Szeimies RM. A randomized, active-controlled, phase III multi-national trial to evaluate the safety and efficacy of BF-200 ALA (Ameluz®) versus MAL cream in the treatment of non-aggressive basal cell carcinoma with photodynamic therapy (PDT). Br J Dermatol 2018; 179: 309-319
Schmitz L, Gambichler T, Gupta G, Stockfleth E, Dirschka T. Actinic keratosis area and severity index (AKASI) is associated with the incidence of squamous cell carcinoma. JEADV 2018; 32: 752-756
Schmitz L, Gambichler T, Gupta G, Stücker M, Stockfleth E, Szeimies RM, Dirschka T. Actinic keratoses show variable histological basal growth patterns – a proposed classification adjustment. JEADV 2018; 32: 745-751
- MB ChB University of Manchester 1990
- FRCP Royal College of Physicians and Surgeons of Glasgow 2007
Reference number 3469563
Professional bodies (positions held - last 3 yrs)
- Member National Cancer Research Institute 2017
- Fellow Royal College of Physicians and Surgeons of Glasgow 2003
Details of entry to specialist register
- Certificate of Completion of Specialist Training in Dermatology, 1999
Affiliations / memberships
Member of British Association of Dermatologists.
Member of Scottish Skin Cancer Group.
Member of Scottish Dermatology Society
- BMI Ross Hall Hospital, G52 3NQ
- 13:00 - 19:00
- 0141 810 3151
- Nuffield Health Glasgow Hospital, G12 0PJ
- 13:00 - 19:00
- 0141 334 9441
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details
Dr Girish Gupta (07767 652 842)